Ontology highlight
ABSTRACT:
SUBMITTER: Ferguson FM
PROVIDER: S-EPMC5066161 | biostudies-literature | 2016 Oct
REPOSITORIES: biostudies-literature
ACS medicinal chemistry letters 20160802 10
Dual inhibition of PI3K-δ and PI3K-γ is an established therapeutic strategy for treatment of hematological malignancies. Reported molecules targeting PI3K-δ/γ selectively are chemically similar and based upon isoquinolin-1(2<i>H</i>)-one or quinazolin-4(3<i>H</i>)-one scaffolds. Here we report a chemically distinct series of potent, selective PI3K-δ/γ inhibitors based on a 5,11-dihydro-6<i>H</i>-benzo[<i>e</i>]pyrimido[5,4-<i>b</i>][1,4]diazepin-6-one scaffold with comparable biochemical potency ...[more]